You are here

Treatment of Agitation by drug Aerosol Inhalation

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43MH068926-01A1
Agency Tracking Number: MH068926
Amount: $196,998.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ALEXZA MOLECULAR DELIVERY CORPORATION 1001 E MEADOW CIR
PALO ALTO, CA 94303
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 PATRIK Munzar
 (650) 687-3922
 PMUNZAR@ALEXZA.COM
Business Contact
 JOSHUA RABINOWITZ
Phone: (650) 687-3902
Email: JRABINOWITZ@ALEXZA.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Acute agitation is a serious and common complication of a variety of major psychiatric disorders, including dementia, schizophrenia and mania. In addition, it is one of the most detrimental factors in the continued

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government